Decline in serumandrogens and survival in metastatic castration resistant prostate cancer (mCRPC) patients treated with docetaxel and prednisone: results from CALGB 90401 (Alliance)
- Citation:
- Eur Urol vol 17 (2) e1073
- Meeting Instance:
- EAU 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- Yes
- Parents:
- None
- Children:
- 3120
- Pharmas:
- Genentech
- Grants:
- R21 CA195424-01, U10CA180821, U10CA180882, U24CA196171
- Corr. Author:
- Authors:
- Charles J Ryan Sandipan Dutta William K Kelly Carly Russell Eric J. Small Michael J. Morris Mary-Ellen Taplin Susan Halabi
- Networks:
- CA136, LAPS-MA036, LAPS-NY016, MN022
- Study
- CALGB-90401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: